Lymphocyte ectoenzymes in childhood idiopathic nephrotic syndrome

Pediatric Nephrology

Volumn 12, Issue 9, 1998, Pages 755-760

  Stefanović, Vladisav ^a   Golubović, Emilija ^a   Vlahović, Predrag ^a   Mitić Zlatković, Marina ^a  

^a Faculty of Medicine   (Serbia)

Author keywords

Alkaline phosphodiesterase I; Concanavalin A; Dipeptidylpeptidase IV; Focal segmental glomerulosclerosis; Idiopathic nephrotic syndrome; Lymphocyte ectoenzymes; Minimal change disease

Indexed keywords

CONCANAVALIN A; CORTICOSTEROID; DIPEPTIDYL PEPTIDASE IV; ECTO 5' NUCLEOTIDASE; LYMPHOCYTE ENZYME; PHOSPHODIESTERASE I; POKEWEED MITOGEN;

ADOLESCENT; ARTICLE; CELL FUNCTION; CELL STIMULATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ENZYME ACTIVITY; FEMALE; FOCAL GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RELAPSE; REMISSION; T LYMPHOCYTE;

EID: 0031733533     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050540     Document Type: Article

References (39)

1. International Study of Kidney Disease in Children (1978) The nephrotic syndrome in children. Prediction of histopathology from clinical and laboratory characteristics at the time of diagnosis. Kidney Int 13:139-165
2. Schnaper HW (1989) The immune system in minimal change nephrotic syndrome. Pediatr Nephrol 3:101-110
3. Ichikawa I, Fogo A (1996) Focal segmental glomerulosclerosis. Pediatr Nephrol 10:374-391
4. Fiser RT, Arnold WC, Charlton RK, Steele RW, Childress SH, Shirkey B (1991) T-lymphocyte subsets in nephrotic syndrome. Kidney Int 40:913-916
5. Hulton SA, Shah V, Byrne MR, Morgan G, Barratt TM, Dillon MJ (1994) Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 8:135-139
6. Joffe MI, Robson AR (1978) Dissociation of lymphokine production and blastogenesis in children with measles infection Clin Immunol Immunopathol 10:335-343
7. Matsumoto K, Osakabe K, Harada M, Hatano M (1981) Impaired cell mediated immunity in lipoid nephrosis. Nephron 29:190-194
8. Matsumoto K (1982) Impaired local graft-versus-host reaction in lipoid nephrosis. Nephron 31:281-282
9. Kucharska K, Kowalczyk D, Sancewicz-Pach K, Zembala M (1979) Mononuclear cell migration inhibition in children with nephrotic syndrome. Acta Paediatr Scand 68:81-84
10. Lin CY (1988) Decreased antibody-dependent cellular cytotoxicity in minimal change nephrotic syndrome. Pediatr Nephrol 2:224-228
11. Schnaper HW, Pierce CW, Aune TM (1984) Identification and initial characterization of concanavalin A- and interferon-induced human suppressor factors: evidence for a human equivalent of murine soluble immune response suppressor (SIRS). J Immunol 132:2429-2435
12. Aune TM, Pierce CW (1982) Activation of a suppressor T-cell pathway by interferon. Proc Natl Acad Sci USA 79:3808-3812
13. Schnaper HW, Aune TM (1987) Steroid-sensitive mechanism of soluble immune response suppressor production in steroidresponsive nephrotic syndrome. J Clin Invest 79:257-264
14. Schnaper HW, Aune TM (1985) Identification of the lymphokine soluble immune response suppressor in urine of nephrotic children. J Clin Invest 76:341-349
15. Lagrue G, Xheneumont S, Branellec A, Hirbec G, Weil B (1975) A vascular permeability factor elaborated from lymphocytes. Demonstration in patients with nephrotic syndrome. Biomedicine 23:37-40
16. Garin EH, Blanchard DK, Matsushima K, Djeu JY (1994) IL-8 production by peripheral blood mononuclear cells in nephrotic patients. Kidney Int 45:1311-1317
17. Matsumoto K (1995) Decreased release of IL-10 by monocytes with lipoid nephrosis Clin Exp Immunol 102:603-607
18. Schnaper HW (1989) The soluble immune response suppressor pathway in nephrotic syndrome. Semin Nephrol 9:107-111
19. Takeda T, Nakagawa Y, Narita I, Kimura H, Kutsuwada T, Arakawa M (1995) Identification and characterization of specifically expressed genes in mononuclear cells from patients with glomerulosclerosis (abstract). J Am Soc Nephrol 6:854
20. Stefanović V, Savić V, Vlahović P, Ardaillou N, Ardaillou R (1989) Macrophages selectively stimulate ecto-5′-nucleotidase activity of cultured mesangial cells. Kidney Int 36:249-256
21. Stefanović V, Vlahović P, Savić V (1995) Effect of glomerular cells interaction with macrophages on surface 5′-nucleotidase actiivity. Arch Physiol Biochem 103:462-465
22. Kenny AJ, O'Hare MJ, Gusterson BA (1989) Cell-surface peptidases as modulators of growth and differentiation. Lancet II:785-787
23. Stefanović V, Vlahović P, Ardaillou R (1995) Characterization and control of expression of cell surface alkaline phosphodiesterase I activity in rat mesangial glomerular cells. Renal Physiol Biochem 18:12-20
24. Stefanović V, Ardaillou N, Vlahović P, Placier S, Ronco P, Ardaillou R (1993) Interferon-γ induces dipeptidylpeptidase IV expression in human glomerular epithelial cells. Immunology 80:465-470
25. Rebbe NF, Tong BD, Finley EM, Hickman S (1991) Identification of nucleotide pyrophosphatase/alkaline phosphodiesterase I activity associated with the mouse plasma cell differentation antigen PC-I. Proc Natl Acad Sci U S A 88:5195-5196
26. Rebbe NF, Hickman S (1991) Modulation of nucleotide pyrophosphatase in plasmocytoma cells. Biochem Biophys Res Commun 175:637-644
27. Stefanović V, Djordjević V, Mitić M (1995) Receptor-mediated induction of human glomerular epithelial cell alkaline phosphodiesterase I by glucocorticoids. Arch Physiol Biochem 103:427-430
28. Schon E, Ansorge S (1990) Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes. Biol Chem Hoppe Seyler 371:699-705
29. Schon E, Demuth HU, Eichmann E, Horst H-J, Korner I-J, Mattern T, Neubert K, Noll F, Ulmer AJ, Barth A, Ansorge S (1989) Dipeptidylpeptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand J Immunol 29:127-132
30. Kubota T, Flentke W, Bachovchin W, Stollar BD (1992) Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol 89:192-197
31. Thompson LF, Boss GR, Spiegelberg HL, Jansen IV, O'Connor RD, Waldmann TA, Hamburger RN, Seegmiller JE (1979) Ecto-5′-nucleotidase activity in T and B lymphocytes from normal subjects and patients with congenital X-linked agammaglobulinemia. J Immunol 123:2475-2478
32. + lymphocytes. J Immunol 137:484-488
33. Kammer GM (1987) Adenosine: emerging role as an immunomodifying agent. J Lab Clin Med 110:255-256
34. Cronstein BN, Kramer SB, Wessmann G, Hirschhorn R (1983) Adenosine: a physiological modulator of superoxide anion generation by human neutrophils. J Exp Med 158:1160-1177
35. Savić V, Stefanović V, Ardaillou N, Ardaillou R (1990) Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1β and tumor necrosis factor-α. Immunology 70:321-326
36. Diamond JR, Karnovsky MJ (1986) Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside. Am J Pathol 122:481-487
37. Fogo A, Hawkins EP, Berry PL, Glick AD, Chiang ML, MacDonell RC, Ichikawa I (1990) Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal segmental glomerulosclcrosis. Kidney Int 38:115-123
38. Vats AN, Basgen GM, Steffes M, Mauer M (1994) Mean glomerular volume (GV) in minimal change nephrotic syndrome (MCNS), focal segmental glomerulosclerosis (FSGS), normal children and adults (abstract). J Am Soc Nephrol 5:797
39. Vats AN, Basgen GM, Steffes M, Mauer M (1994) Glomerular number in focal segmental glomerulosclerosis (FSGS) and minimal change nephrotic syndrome (MCNS) (abstract). J Am Soc Nephrol 5:797